Strength Training Effective for Managing Blood Pressure, Study Finds

Health & Lifestyle
485

Translate to Spanish or other 102 languages!

Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes
Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes

Medical News Today

- Advertisement -
  • High blood pressure or hypertension is a common condition that can lead to serious problems without proper management. 
  • High blood pressure management can involve using medications and lifestyle modifications. 
  • Data from a systematic review and meta-analysis found that strength training may be an effective non-medication option for the management of high blood pressure. However, its effectiveness depends on factors like intensity level and duration.

Follow the link below to read the full story on Medical News Today: https://www.medicalnewstoday.com/articles/hypertension-strength-training-helps-manage-high-blood-pressure?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-04-14&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
No Amount of Alcohol is Safe for Your Heart
Next article
What You NEED to Know About Chagas Disease

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Golden Years, Restless Nights: How Aging Transforms Your Sleep Cycles

If you have trouble falling asleep or staying asleep, your age could be playing a role.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.
- Advertisement -